Cardiac involvement in muscular dystrophies

QJM: An International Journal of Medicine

Volumn 101, Issue 5, 2008, Pages 337-344

  Beynon, R P ^a   Ray, S G ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DYSTROPHIN; ENALAPRIL; MYOTONIC DYSTROPHY PROTEIN KINASE; PERINDOPRIL;

ADD ON THERAPY; ARTIFICIAL HEART PACEMAKER; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; BECKER MUSCULAR DYSTROPHY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DUCHENNE MUSCULAR DYSTROPHY; ELECTROCARDIOGRAPHY MONITORING; EMERY DREIFUSS MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE MUTATION; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART TRANSPLANTATION; HETEROZYGOSITY; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; LONG TERM CARE; MUSCULAR DYSTROPHY; MYOTONIC DYSTROPHY; ONSET AGE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCREENING; SUDDEN DEATH; X CHROMOSOME LINKED DISORDER;

EID: 42949110086     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcm124     Document Type: Review

References (62)

1. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms. Cell 2001; 104:557-67.
2. Emery AE. Population frequencies of inherited neuromuscular diseases - a world survey. Neuromuscul Disord 1991; 1:19-29.
3. Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, et al. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 2005; 112:2799-804.
4. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51:919-28.
5. McNally E, Allikian M, Wheeler MT, Mislow JM, Heydemann A. Cytoskeletal defects in cardiomyopathy. J Mol Cell Cardiol 2003; 35:231.
6. Mathieu J, Allard P, Potvin L, Prevost C, Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999; 52:1658-62.
7. Bushby K, Muntoni F, Bourke JP. 107th ENMC international workshop: The management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, The Netherlands. Neuromuscul Disord 2003; 13:166-72.
8. Melacini P, Vianello A, Villanova C, Fanin M, Miorin M, Angelini C, et al. Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. Neuromuscul Disord 1996; 6:367-76.
9. Nigro G, Comi LI, Politano L, Bain RJ. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990; 26:271-7.
10. Perloff JK, Roberts WC, de Leon AC Jr, O'Doherty D. The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic-pathologic correlative study. Am J Med 1967; 42:179-88.
11. Perloff JK, Henze E, Schelbert HR. Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. Circulation 1984; 69:33-42.
12. Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, et al. Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 2002; 89:838-41.
13. Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G, Becane HM. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 2005; 45:855-7
14. Ramaciotti C, Heistein LC, Coursey M, Lemler MS, Eapen RS, Iannaccone ST, et al. Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life. Am J Cardiol 2006; 98:825.
15. Kajimoto H, Ishigaki K, Okumura K, Tomimatsu H, Nakazawa M, Saito K, et al. Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. Circ J 2006; 70:991-4.
16. Grain L, Cortina-Borja M, Forfar C, Hilton-Jones D, Hopkin J, Burch M. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls. Neuromuscul Disord 2001; 11:186-91.
17. Hoogerwaard EM, van der Wouw PA, Wilde AA, Bakker E, Ippel PF, Oosterwijk JC, et al. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 1999; 9 347-51.
18. Nolan MA, Jones OD, Pedersen RL, Johnston HM. Cardiac assessment in childhood carriers of Duchenne and Becker muscular dystrophies. Neuromuscul Disord 2003; 13:129-32.
19. Bushby KM, Thambyayah M, Gardner-Medwin D. Prevalence and incidence of Becker muscular dystrophy. Lancet 1991; 337:1022-4.
20. Saito M, Kawai H, Akaike M, Adachi K, Nishida Y, Saito S. Cardiac dysfunction with Becker muscular dystrophy. Am Heart J 1996; 132:642-7.
21. Nigro G, Comi LI, Politano L, Limongelli FM, Nigro V, De Rimini ML, et al. Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve 1995; 18:283-91.
22. Finsterer J, Bittner RE, Grimm M. Cardiac involvement in Becker's muscular dystrophy, necessitating heart transplantation, 6 years before apparent skeletal muscle involvement. Neuromuscul Disord 1999; 9:598-600.
23. Casazza F, Brambilla G, Salvato A, Morandi L, Gronda E, Bonacina E. Cardiac transplantation in Becker muscular dystrophy. J Neurol 1988; 235:496-8.
24. Piccolo G, Azan G, Tonin P, Arbustini E, Gavazzi A, Banfi P, et al Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy. Neuromuscul Disord 1994; 4:143-6.
25. Emery AE, Dreifuss FE. Unusual type of benign x-linked muscular dystrophy. J Neurol Neurosurg Psychiatry 1966; 29:338-42.
26. Bonne G, Di Barletta MR, Varnous S, Becane HM, Hammouda EH, Merlini L, et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999; 21 285-8.
27. Boriani G, Gallina M, Merlini L, Bonne G, Toniolo D, Amati S, et al Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: A long-term longitudinal study. Stroke 2003; 34: 901-8.
28. Sakata K, Shimizu M, Ino H, Yamaguchi M, Terai H, Fujino N, et al. High incidence of sudden cardiac death with conduction disturbances and atrial cardiomyopathy caused by a nonsense mutation in the STA gene. Circulation 2005; 111:3352-8.
29. Goldman RD, Gruenbaum Y, Moir RD, Shumaker DK, Spann TP. Nuclear lamins: building blocks of nuclear architecture. Genes Dev 2002; 16 533-47.
30. Bonne G, Mercuri E, Muchir A, Urtizberea A, Becane HM, Recan D, et al Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 2000; 48:170-80.
31. Becane HM, Bonne G, Varnous S, Muchir A, Ortega V, Hammouda EH, et al High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol 2000; 23(11 Pt 1):1661-6.
32. Laforet P, de Toma C, Eymard B, Becane HM, Jeanpierre M, Fardeau M, et al. Cardiac involvement in genetically confirmed facioscapulohumeral, muscular dystrophy. Neurology 1998; 51 1454-6.
33. Stevenson WG, Perloff JK, Weiss JN, Anderson TL. Facioscapulohumeral muscular dystrophy: Evidence for selective, genetic electrophysiologic cardiac involvement. J Am Coll Cardiol 1990; 15:292-9.
34. de Visser M, de Voogt WG, la Riviere GV. The heart in Becker muscular dystrophy, facioscapulohumeral dystrophy, and Bethlem myopathy. Muscle Nerve 1992; 15:591-6.
35. Trevisan CP, Pastorello E, Armani M, Angelini C, Nante G, Tomelleri G, et al. Facioscapulohumeral muscular dystrophy and occurrence of heart arrhythmia. Eur Neurol 2006; 56:1-5.
36. Emery AEH. Population frequencies of inherited neuromuscular diseases - A world survey. Neuromuscular Disord 1991; 1:19.
37. Bushby KMD. Diagnostic criteria for the limb-girdle muscular dystrophies: Report of the ENMC consortium on limbgirdle dystrophies. Neuromuscular Disord 1995; 5:71.
38. Passos-Bueno MR, Mariz Vainzof Eloisa S, Zatz MM. Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G. Am J Med Genet 1999; 82:392-8.
39. Politano L, Nigro V, Passamano L, Petretta V, Comi LI, Papparella S, et al. Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscular Disord 2001; 11: 178-85.
40. Zatz M, de Paula F, Starling A, Vainzof M. The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromuscular Disord 2003; 13 532.
41. van der Kooi AJ, de Voogt WG, Barth PG, Busch HF, Jennekens FG, Jongen PJ, et al. The heart in limb girdle muscular dystrophy. Heart 1998; 79:73-7.
42. Mostacciuolo ML, Miorin M, Martinello F, Angelini C, Perini P, Trevisan CP. Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy. Hum Genet 1996; 97:277-9.
43. Kirschner J, Bonnemann CG. The congenital and limb-girdle muscular dystrophies: Sharpening the focus, blurring the boundaries. Arch Neurol 2004; 61:189-99.
44. Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, Benson MA, et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 21 as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 2001; 10 2851-9.
45. Harper PS. Myotonic Dystrophy., 2nd edn. Philadelphia, London: Saunders, 1989.
46. Pelargonio G, Dello Russo A, Sanna T, De Martino G, Bellocci F. Myotonic dystrophy and the heart. Heart 2002; 88:665-70.
47. Finsterer J, Gharehbaghi-Schnell E, Stollberger C, Fheodoroff K, Seiser A. Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy. Clin Genet 2001; 59:350-5.
48. Tokgozoglu LS, Ashizawa T, Pacifico A, Armstrong RM, Epstein HF, Zoghbi WA. Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion. JAMA 1995; 274:813-9.
49. Hadian D, Lowe MR, Scott LR, Groh WJ. Use of an insertable loop recorder in a myotonic dystrophy patient. J Cardiovasc Electrophysiol 2002; 13:72-3.
50. Bassez G, Lazarus A, Desguerre I, Varin J, Laforet P, Becane HM, et al. Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1. Neurology 2004; 63:1939-41.
51. Lazarus A, Varin J, Ounnoughene Z, Radvanyi H, Junien C, Coste J, et al. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation 1999; 99:1041-6.
52. Merino JL, Carmona JR, Fernandez-Lozano I, Peinado R, Basterra N, Sobrino JA. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: Implications for catheter ablation. Circulation 1998; 98:541-6.
53. Badano L, Autore C, Fragola PV, Picelli A, Antonini G, Vichi R, et al Left ventricular myocardial function in myotonic dystrophy. Am J Cardiol 1993; 71:987-91.
54. Schoser BGH, Ricker K, Schneider-Gold C, Hengstenberg C, Durre J, Bultmann B, et al. Sudden cardiac death in myotonic dystrophy type 2. Neurology 2004; 63:2402-4.
55. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, et al Myotonic dystrophy type 2: Molecular, diagnostic and clinical spectrum. Neurology 2003; 60:657-64.
56. Meune C, Pascal O, Becane HM, Heloire F, Christoforou D, Laforet P, et al. Reliable detection of early myocardial dysfunction by tissue Doppler echocardiography in Becker muscular dystrophy. Heart 2004; 90:947-8.
57. Soler R, Rodriguez E, Remuinan C, Bello MJ, Diaz A. Magnetic resonance imaging of primary cardiomyopathies. J Comput Assist Tomogr 2003; 27:724-34.
58. Gaul C, Deschauer M, Tempelmann C, Vielhaber S, Klein HU, Heinze HJ, et al. Cardiac involvement in limb-girdle muscular dystrophy 21: conventional cardiac diagnostic and cardiovascular magnetic resonance. J Neurol 2006; 253:1317-22.
59. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002; 90:29-34.
60. Lanza GA, Russo AD, Giglio V, De Luca L, Messano L, Santini C, et al Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: Relationship to myocardial, and respiratory function. Am Heart J 2001; 141:808.
61. Leo RD, Rodolico C, Gregorio CD, Recupero A, Coglitore S, Annesi G, et al. Cardiovascular autonomic control in myotonic dystrophy type 1: a correlative study with clinical and genetic data. Neuromuscular Disord 2004; 14:136.
62. Ammendola E, Russo V, Politano L, Santangelo L, Calabro R. Is heart rate variability a valid parameter to predict sudden death in patients with Becker's muscular dystrophy? Heart 2006; 92:1686-7.